Conscious sedation and vertebroplasty

Safety and efficacy of propofol and remifentanyl vs meperdine and midazolam as a conscious sedation in percutenous vertebroplasty :prospective randomized study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201801002914411

Enrollment

Registered

2017-12-28

Start date

2017-12-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases conscious sedation ,vertebroplasty Anaesthesia

Interventions

conscious sedation in percutenous vertebroplasty

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Sixty patients American Society of Anesthesiologists (ASA) Grade I and II aged from 18 to 65 years of either sex undergoing percutaneous vertebroplasty for vertebral compression fractures, metastatic fractures of the spine

Exclusion criteria

Exclusion criteria: Patients with known allergies to any drug used in the study patients with a pregnancy patients on sustained release narcotics and substance abuse patients not giving consent

Design outcomes

Primary

Measure	Time frame
time to reach conscious sedation level;time to recovery from conscious sedation ;hemodynamic stability during procedure	—

Secondary

Measure	Time frame
side effects (nausea and vomiting );patients and surgeons satisfaction score	—

Countries

Egypt

Contacts

Public ContactEman Salama

lecture

dr.ers1975@yahoo.com01225865765

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026